nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Sorafenib—thyroid cancer	0.0731	0.369	CbGbCtD
Imiquimod—CYP3A4—Vandetanib—thyroid cancer	0.0635	0.321	CbGbCtD
Imiquimod—CYP3A4—Sorafenib—thyroid cancer	0.0383	0.193	CbGbCtD
Imiquimod—CYP3A4—Doxorubicin—thyroid cancer	0.0232	0.117	CbGbCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CDK1—thyroid cancer	0.00505	0.0573	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—CDK1—thyroid cancer	0.00495	0.0562	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—CDK1—thyroid cancer	0.00478	0.0543	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IFNA2—thyroid cancer	0.00423	0.0481	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CDK1—thyroid cancer	0.00382	0.0434	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—CDK1—thyroid cancer	0.00375	0.0426	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—CDK1—thyroid cancer	0.00362	0.0411	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—CDK1—thyroid cancer	0.0034	0.0386	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IFNA2—thyroid cancer	0.0033	0.0375	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IFNA2—thyroid cancer	0.00321	0.0364	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—CDK1—thyroid cancer	0.00257	0.0292	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IFNA2—thyroid cancer	0.0025	0.0284	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RAP1GAP—thyroid cancer	0.00165	0.0187	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—LGALS3—thyroid cancer	0.00161	0.0183	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PRKAR1A—thyroid cancer	0.0016	0.0181	CbGpPWpGaD
Imiquimod—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00154	0.0175	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00153	0.0173	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00149	0.0169	CbGpPWpGaD
Imiquimod—Inflammation—Epirubicin—thyroid cancer	0.00139	0.00195	CcSEcCtD
Imiquimod—Asthenia—Vandetanib—thyroid cancer	0.00139	0.00194	CcSEcCtD
Imiquimod—Viral infection—Doxorubicin—thyroid cancer	0.00138	0.00194	CcSEcCtD
Imiquimod—Hypertension—Sorafenib—thyroid cancer	0.00138	0.00193	CcSEcCtD
Imiquimod—Pruritus—Vandetanib—thyroid cancer	0.00137	0.00192	CcSEcCtD
Imiquimod—Arthralgia—Sorafenib—thyroid cancer	0.00136	0.00191	CcSEcCtD
Imiquimod—Myalgia—Sorafenib—thyroid cancer	0.00136	0.00191	CcSEcCtD
Imiquimod—Herpes simplex—Doxorubicin—thyroid cancer	0.00136	0.0019	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00135	0.00189	CcSEcCtD
Imiquimod—Vaginal inflammation—Epirubicin—thyroid cancer	0.00135	0.00189	CcSEcCtD
Imiquimod—Dry mouth—Sorafenib—thyroid cancer	0.00133	0.00186	CcSEcCtD
Imiquimod—Diarrhoea—Vandetanib—thyroid cancer	0.00132	0.00185	CcSEcCtD
Imiquimod—Ulcer—Doxorubicin—thyroid cancer	0.00132	0.00185	CcSEcCtD
Imiquimod—Influenza like illness—Epirubicin—thyroid cancer	0.00131	0.00184	CcSEcCtD
Imiquimod—Bone pain—Doxorubicin—thyroid cancer	0.0013	0.00183	CcSEcCtD
Imiquimod—Infection—Sorafenib—thyroid cancer	0.0013	0.00181	CcSEcCtD
Imiquimod—Skin exfoliation—Epirubicin—thyroid cancer	0.00129	0.00181	CcSEcCtD
Imiquimod—Inflammation—Doxorubicin—thyroid cancer	0.00129	0.00181	CcSEcCtD
Imiquimod—Shock—Sorafenib—thyroid cancer	0.00128	0.0018	CcSEcCtD
Imiquimod—Nervous system disorder—Sorafenib—thyroid cancer	0.00128	0.00179	CcSEcCtD
Imiquimod—Dizziness—Vandetanib—thyroid cancer	0.00128	0.00179	CcSEcCtD
Imiquimod—Vaginal infection—Epirubicin—thyroid cancer	0.00128	0.00179	CcSEcCtD
Imiquimod—Skin disorder—Sorafenib—thyroid cancer	0.00127	0.00177	CcSEcCtD
Imiquimod—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00125	0.00175	CcSEcCtD
Imiquimod—TLR7—Immune System—RAP1GAP—thyroid cancer	0.00125	0.0142	CbGpPWpGaD
Imiquimod—Anorexia—Sorafenib—thyroid cancer	0.00124	0.00174	CcSEcCtD
Imiquimod—Vomiting—Vandetanib—thyroid cancer	0.00123	0.00172	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—LGALS3—thyroid cancer	0.00122	0.0139	CbGpPWpGaD
Imiquimod—Rash—Vandetanib—thyroid cancer	0.00122	0.00171	CcSEcCtD
Imiquimod—Dermatitis—Vandetanib—thyroid cancer	0.00122	0.00171	CcSEcCtD
Imiquimod—Influenza like illness—Doxorubicin—thyroid cancer	0.00121	0.0017	CcSEcCtD
Imiquimod—Headache—Vandetanib—thyroid cancer	0.00121	0.0017	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PRKAR1A—thyroid cancer	0.00121	0.0137	CbGpPWpGaD
Imiquimod—Pulmonary oedema—Epirubicin—thyroid cancer	0.0012	0.00168	CcSEcCtD
Imiquimod—Skin exfoliation—Doxorubicin—thyroid cancer	0.00119	0.00167	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00119	0.00166	CcSEcCtD
Imiquimod—Vaginal infection—Doxorubicin—thyroid cancer	0.00118	0.00165	CcSEcCtD
Imiquimod—Dyspnoea—Sorafenib—thyroid cancer	0.00116	0.00163	CcSEcCtD
Imiquimod—Lymphadenopathy—Epirubicin—thyroid cancer	0.00115	0.00161	CcSEcCtD
Imiquimod—Nausea—Vandetanib—thyroid cancer	0.00115	0.00161	CcSEcCtD
Imiquimod—Dyspepsia—Sorafenib—thyroid cancer	0.00115	0.00161	CcSEcCtD
Imiquimod—Decreased appetite—Sorafenib—thyroid cancer	0.00113	0.00159	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00113	0.00158	CcSEcCtD
Imiquimod—Fatigue—Sorafenib—thyroid cancer	0.00112	0.00157	CcSEcCtD
Imiquimod—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00112	0.00157	CcSEcCtD
Imiquimod—Pain—Sorafenib—thyroid cancer	0.00111	0.00156	CcSEcCtD
Imiquimod—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00111	0.00156	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CDK1—thyroid cancer	0.0011	0.0125	CbGpPWpGaD
Imiquimod—Eczema—Epirubicin—thyroid cancer	0.00109	0.00153	CcSEcCtD
Imiquimod—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00107	0.00149	CcSEcCtD
Imiquimod—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00106	0.00149	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IFNA2—thyroid cancer	0.00106	0.012	CbGpPWpGaD
Imiquimod—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00104	0.00146	CcSEcCtD
Imiquimod—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00104	0.00145	CcSEcCtD
Imiquimod—Urticaria—Sorafenib—thyroid cancer	0.00104	0.00145	CcSEcCtD
Imiquimod—Abdominal pain—Sorafenib—thyroid cancer	0.00103	0.00144	CcSEcCtD
Imiquimod—Body temperature increased—Sorafenib—thyroid cancer	0.00103	0.00144	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.00102	0.0116	CbGpPWpGaD
Imiquimod—Purpura—Epirubicin—thyroid cancer	0.00102	0.00143	CcSEcCtD
Imiquimod—Eczema—Doxorubicin—thyroid cancer	0.00101	0.00141	CcSEcCtD
Imiquimod—Cardiac failure—Epirubicin—thyroid cancer	0.001	0.00141	CcSEcCtD
Imiquimod—Lethargy—Epirubicin—thyroid cancer	0.001	0.0014	CcSEcCtD
Imiquimod—Cerebrovascular accident—Epirubicin—thyroid cancer	0.001	0.0014	CcSEcCtD
Imiquimod—Pain in extremity—Epirubicin—thyroid cancer	0.00098	0.00137	CcSEcCtD
Imiquimod—Migraine—Epirubicin—thyroid cancer	0.000965	0.00135	CcSEcCtD
Imiquimod—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000961	0.00135	CcSEcCtD
Imiquimod—Hypersensitivity—Sorafenib—thyroid cancer	0.000961	0.00135	CcSEcCtD
Imiquimod—Face oedema—Epirubicin—thyroid cancer	0.000946	0.00133	CcSEcCtD
Imiquimod—TLR8—Immune System—TPR—thyroid cancer	0.000946	0.0107	CbGpPWpGaD
Imiquimod—Purpura—Doxorubicin—thyroid cancer	0.000941	0.00132	CcSEcCtD
Imiquimod—TLR8—Immune System—LGALS3—thyroid cancer	0.000938	0.0106	CbGpPWpGaD
Imiquimod—Asthenia—Sorafenib—thyroid cancer	0.000935	0.00131	CcSEcCtD
Imiquimod—TLR8—Immune System—PRKAR1A—thyroid cancer	0.00093	0.0106	CbGpPWpGaD
Imiquimod—Cardiac failure—Doxorubicin—thyroid cancer	0.000929	0.0013	CcSEcCtD
Imiquimod—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000926	0.0013	CcSEcCtD
Imiquimod—Lethargy—Doxorubicin—thyroid cancer	0.000926	0.0013	CcSEcCtD
Imiquimod—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000923	0.0105	CbGpPWpGaD
Imiquimod—Pruritus—Sorafenib—thyroid cancer	0.000922	0.00129	CcSEcCtD
Imiquimod—Pain in extremity—Doxorubicin—thyroid cancer	0.000907	0.00127	CcSEcCtD
Imiquimod—Migraine—Doxorubicin—thyroid cancer	0.000893	0.00125	CcSEcCtD
Imiquimod—Diarrhoea—Sorafenib—thyroid cancer	0.000892	0.00125	CcSEcCtD
Imiquimod—Breast disorder—Epirubicin—thyroid cancer	0.000886	0.00124	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—NRG1—thyroid cancer	0.000883	0.01	CbGpPWpGaD
Imiquimod—Face oedema—Doxorubicin—thyroid cancer	0.000876	0.00123	CcSEcCtD
Imiquimod—Dizziness—Sorafenib—thyroid cancer	0.000862	0.00121	CcSEcCtD
Imiquimod—Influenza—Epirubicin—thyroid cancer	0.000847	0.00119	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CDK1—thyroid cancer	0.000834	0.00947	CbGpPWpGaD
Imiquimod—Vomiting—Sorafenib—thyroid cancer	0.000829	0.00116	CcSEcCtD
Imiquimod—Rash—Sorafenib—thyroid cancer	0.000822	0.00115	CcSEcCtD
Imiquimod—Dermatitis—Sorafenib—thyroid cancer	0.000821	0.00115	CcSEcCtD
Imiquimod—Breast disorder—Doxorubicin—thyroid cancer	0.00082	0.00115	CcSEcCtD
Imiquimod—Headache—Sorafenib—thyroid cancer	0.000817	0.00114	CcSEcCtD
Imiquimod—Bronchitis—Epirubicin—thyroid cancer	0.000815	0.00114	CcSEcCtD
Imiquimod—Pancytopenia—Epirubicin—thyroid cancer	0.000805	0.00113	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—IFNA2—thyroid cancer	0.000802	0.0091	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	0.000796	0.00904	CbGpPWpGaD
Imiquimod—Dysuria—Epirubicin—thyroid cancer	0.000792	0.00111	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000787	0.0011	CcSEcCtD
Imiquimod—Influenza—Doxorubicin—thyroid cancer	0.000784	0.0011	CcSEcCtD
Imiquimod—Nausea—Sorafenib—thyroid cancer	0.000774	0.00109	CcSEcCtD
Imiquimod—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000773	0.00108	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	0.000773	0.00877	CbGpPWpGaD
Imiquimod—Infestation—Epirubicin—thyroid cancer	0.000755	0.00106	CcSEcCtD
Imiquimod—Infestation NOS—Epirubicin—thyroid cancer	0.000755	0.00106	CcSEcCtD
Imiquimod—Bronchitis—Doxorubicin—thyroid cancer	0.000754	0.00106	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000749	0.00105	CcSEcCtD
Imiquimod—Pancytopenia—Doxorubicin—thyroid cancer	0.000745	0.00104	CcSEcCtD
Imiquimod—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000741	0.00104	CcSEcCtD
Imiquimod—Conjunctivitis—Epirubicin—thyroid cancer	0.000734	0.00103	CcSEcCtD
Imiquimod—Urinary tract infection—Epirubicin—thyroid cancer	0.000734	0.00103	CcSEcCtD
Imiquimod—Dysuria—Doxorubicin—thyroid cancer	0.000733	0.00103	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000729	0.00102	CcSEcCtD
Imiquimod—TLR7—Immune System—TPR—thyroid cancer	0.000717	0.00814	CbGpPWpGaD
Imiquimod—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000716	0.001	CcSEcCtD
Imiquimod—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000715	0.001	CcSEcCtD
Imiquimod—TLR7—Immune System—LGALS3—thyroid cancer	0.000711	0.00807	CbGpPWpGaD
Imiquimod—Sinusitis—Epirubicin—thyroid cancer	0.000709	0.000993	CcSEcCtD
Imiquimod—TLR7—Immune System—PRKAR1A—thyroid cancer	0.000705	0.008	CbGpPWpGaD
Imiquimod—Infestation NOS—Doxorubicin—thyroid cancer	0.000699	0.000979	CcSEcCtD
Imiquimod—Infestation—Doxorubicin—thyroid cancer	0.000699	0.000979	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000695	0.00789	CbGpPWpGaD
Imiquimod—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000693	0.000971	CcSEcCtD
Imiquimod—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000685	0.00096	CcSEcCtD
Imiquimod—Haemoglobin—Epirubicin—thyroid cancer	0.000682	0.000955	CcSEcCtD
Imiquimod—Rhinitis—Epirubicin—thyroid cancer	0.00068	0.000953	CcSEcCtD
Imiquimod—Conjunctivitis—Doxorubicin—thyroid cancer	0.000679	0.000952	CcSEcCtD
Imiquimod—Urinary tract infection—Doxorubicin—thyroid cancer	0.000679	0.000952	CcSEcCtD
Imiquimod—Haemorrhage—Epirubicin—thyroid cancer	0.000678	0.00095	CcSEcCtD
Imiquimod—Pharyngitis—Epirubicin—thyroid cancer	0.000673	0.000943	CcSEcCtD
Imiquimod—Urinary tract disorder—Epirubicin—thyroid cancer	0.00067	0.000938	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NRG1—thyroid cancer	0.000669	0.0076	CbGpPWpGaD
Imiquimod—Connective tissue disorder—Epirubicin—thyroid cancer	0.000666	0.000934	CcSEcCtD
Imiquimod—Urethral disorder—Epirubicin—thyroid cancer	0.000665	0.000932	CcSEcCtD
Imiquimod—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000661	0.000926	CcSEcCtD
Imiquimod—Sinusitis—Doxorubicin—thyroid cancer	0.000656	0.000919	CcSEcCtD
Imiquimod—Visual impairment—Epirubicin—thyroid cancer	0.000654	0.000916	CcSEcCtD
Imiquimod—Erythema multiforme—Epirubicin—thyroid cancer	0.000641	0.000898	CcSEcCtD
Imiquimod—TLR8—Immune System—CDK1—thyroid cancer	0.000641	0.00727	CbGpPWpGaD
Imiquimod—Eye disorder—Epirubicin—thyroid cancer	0.000634	0.000888	CcSEcCtD
Imiquimod—Tinnitus—Epirubicin—thyroid cancer	0.000632	0.000886	CcSEcCtD
Imiquimod—Haemoglobin—Doxorubicin—thyroid cancer	0.000631	0.000884	CcSEcCtD
Imiquimod—Flushing—Epirubicin—thyroid cancer	0.000629	0.000882	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—thyroid cancer	0.000629	0.000881	CcSEcCtD
Imiquimod—Haemorrhage—Doxorubicin—thyroid cancer	0.000628	0.000879	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—thyroid cancer	0.000623	0.000873	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00062	0.000868	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000617	0.000864	CcSEcCtD
Imiquimod—TLR8—Immune System—IFNA2—thyroid cancer	0.000616	0.007	CbGpPWpGaD
Imiquimod—Angiopathy—Epirubicin—thyroid cancer	0.000615	0.000862	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—thyroid cancer	0.000615	0.000862	CcSEcCtD
Imiquimod—Immune system disorder—Epirubicin—thyroid cancer	0.000613	0.000858	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—thyroid cancer	0.000611	0.000856	CcSEcCtD
Imiquimod—Chills—Epirubicin—thyroid cancer	0.000609	0.000853	CcSEcCtD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000608	0.00691	CbGpPWpGaD
Imiquimod—Arrhythmia—Epirubicin—thyroid cancer	0.000606	0.000849	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—thyroid cancer	0.000605	0.000847	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	0.000603	0.00685	CbGpPWpGaD
Imiquimod—Alopecia—Epirubicin—thyroid cancer	0.000599	0.00084	CcSEcCtD
Imiquimod—Mental disorder—Epirubicin—thyroid cancer	0.000594	0.000833	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—thyroid cancer	0.000593	0.000831	CcSEcCtD
Imiquimod—Erythema—Epirubicin—thyroid cancer	0.00059	0.000827	CcSEcCtD
Imiquimod—Malnutrition—Epirubicin—thyroid cancer	0.00059	0.000827	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—thyroid cancer	0.000586	0.000822	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—thyroid cancer	0.000585	0.00082	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—thyroid cancer	0.000582	0.000816	CcSEcCtD
Imiquimod—Back pain—Epirubicin—thyroid cancer	0.000571	0.0008	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—thyroid cancer	0.000569	0.000798	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—thyroid cancer	0.000567	0.000794	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000566	0.000792	CcSEcCtD
Imiquimod—Chills—Doxorubicin—thyroid cancer	0.000563	0.000789	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—thyroid cancer	0.000561	0.000785	CcSEcCtD
Imiquimod—Alopecia—Doxorubicin—thyroid cancer	0.000555	0.000777	CcSEcCtD
Imiquimod—Mental disorder—Doxorubicin—thyroid cancer	0.00055	0.00077	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—thyroid cancer	0.000548	0.000768	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—thyroid cancer	0.000546	0.000765	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—thyroid cancer	0.000546	0.000765	CcSEcCtD
Imiquimod—Agitation—Epirubicin—thyroid cancer	0.000543	0.00076	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000537	0.00609	CbGpPWpGaD
Imiquimod—Malaise—Epirubicin—thyroid cancer	0.000532	0.000746	CcSEcCtD
Imiquimod—Syncope—Epirubicin—thyroid cancer	0.000529	0.000742	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—thyroid cancer	0.000528	0.00074	CcSEcCtD
Imiquimod—Palpitations—Epirubicin—thyroid cancer	0.000522	0.000731	CcSEcCtD
Imiquimod—Loss of consciousness—Epirubicin—thyroid cancer	0.000519	0.000727	CcSEcCtD
Imiquimod—Cough—Epirubicin—thyroid cancer	0.000515	0.000722	CcSEcCtD
Imiquimod—TLR8—Immune System—NRG1—thyroid cancer	0.000514	0.00584	CbGpPWpGaD
Imiquimod—Convulsion—Epirubicin—thyroid cancer	0.000512	0.000717	CcSEcCtD
Imiquimod—Hypertension—Epirubicin—thyroid cancer	0.00051	0.000714	CcSEcCtD
Imiquimod—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000507	0.00071	CcSEcCtD
Imiquimod—Arthralgia—Epirubicin—thyroid cancer	0.000503	0.000704	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—thyroid cancer	0.000503	0.000704	CcSEcCtD
Imiquimod—Myalgia—Epirubicin—thyroid cancer	0.000503	0.000704	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—thyroid cancer	0.000502	0.000703	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—thyroid cancer	0.000501	0.000702	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000499	0.000699	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—thyroid cancer	0.000497	0.000696	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—thyroid cancer	0.000493	0.00069	CcSEcCtD
Imiquimod—Dry mouth—Epirubicin—thyroid cancer	0.000492	0.000689	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—thyroid cancer	0.00049	0.000686	CcSEcCtD
Imiquimod—TLR7—Immune System—CDK1—thyroid cancer	0.000486	0.00551	CbGpPWpGaD
Imiquimod—Palpitations—Doxorubicin—thyroid cancer	0.000483	0.000676	CcSEcCtD
Imiquimod—Oedema—Epirubicin—thyroid cancer	0.000482	0.000675	CcSEcCtD
Imiquimod—Loss of consciousness—Doxorubicin—thyroid cancer	0.00048	0.000673	CcSEcCtD
Imiquimod—Infection—Epirubicin—thyroid cancer	0.000479	0.000671	CcSEcCtD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000477	0.00541	CbGpPWpGaD
Imiquimod—Cough—Doxorubicin—thyroid cancer	0.000477	0.000668	CcSEcCtD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000474	0.00538	CbGpPWpGaD
Imiquimod—Shock—Epirubicin—thyroid cancer	0.000474	0.000664	CcSEcCtD
Imiquimod—Convulsion—Doxorubicin—thyroid cancer	0.000473	0.000663	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—thyroid cancer	0.000473	0.000662	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—thyroid cancer	0.000472	0.000661	CcSEcCtD
Imiquimod—Tachycardia—Epirubicin—thyroid cancer	0.00047	0.000659	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—thyroid cancer	0.000468	0.000656	CcSEcCtD
Imiquimod—TLR7—Immune System—IFNA2—thyroid cancer	0.000467	0.0053	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Epirubicin—thyroid cancer	0.000466	0.000653	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—thyroid cancer	0.000465	0.000652	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—thyroid cancer	0.000465	0.000652	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—thyroid cancer	0.000465	0.000652	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—thyroid cancer	0.000463	0.000649	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000462	0.000647	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—thyroid cancer	0.00046	0.000644	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—thyroid cancer	0.000459	0.000644	CcSEcCtD
Imiquimod—Dry mouth—Doxorubicin—thyroid cancer	0.000455	0.000637	CcSEcCtD
Imiquimod—Oedema—Doxorubicin—thyroid cancer	0.000446	0.000625	CcSEcCtD
Imiquimod—Infection—Doxorubicin—thyroid cancer	0.000443	0.000621	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PTEN—thyroid cancer	0.000442	0.00502	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000439	0.000615	CcSEcCtD
Imiquimod—Shock—Doxorubicin—thyroid cancer	0.000439	0.000615	CcSEcCtD
Imiquimod—Nervous system disorder—Doxorubicin—thyroid cancer	0.000437	0.000613	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—thyroid cancer	0.000436	0.000611	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—thyroid cancer	0.000435	0.00061	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—thyroid cancer	0.000433	0.000607	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—thyroid cancer	0.000433	0.000606	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000431	0.000604	CcSEcCtD
Imiquimod—Dyspnoea—Epirubicin—thyroid cancer	0.00043	0.000602	CcSEcCtD
Imiquimod—Somnolence—Epirubicin—thyroid cancer	0.000428	0.0006	CcSEcCtD
Imiquimod—Anorexia—Doxorubicin—thyroid cancer	0.000425	0.000595	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—thyroid cancer	0.000424	0.000594	CcSEcCtD
Imiquimod—Decreased appetite—Epirubicin—thyroid cancer	0.000419	0.000587	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000416	0.000583	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—thyroid cancer	0.000415	0.000582	CcSEcCtD
Imiquimod—Pain—Epirubicin—thyroid cancer	0.000412	0.000577	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000406	0.000569	CcSEcCtD
Imiquimod—Insomnia—Doxorubicin—thyroid cancer	0.000403	0.000565	CcSEcCtD
Imiquimod—Paraesthesia—Doxorubicin—thyroid cancer	0.0004	0.000561	CcSEcCtD
Imiquimod—Dyspnoea—Doxorubicin—thyroid cancer	0.000397	0.000557	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—thyroid cancer	0.000397	0.000556	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—thyroid cancer	0.000396	0.000555	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—NRAS—thyroid cancer	0.000395	0.00448	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000394	0.000552	CcSEcCtD
Imiquimod—Dyspepsia—Doxorubicin—thyroid cancer	0.000392	0.00055	CcSEcCtD
Imiquimod—TLR7—Immune System—NRG1—thyroid cancer	0.00039	0.00443	CbGpPWpGaD
Imiquimod—Decreased appetite—Doxorubicin—thyroid cancer	0.000388	0.000543	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000387	0.00439	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000385	0.000539	CcSEcCtD
Imiquimod—Fatigue—Doxorubicin—thyroid cancer	0.000384	0.000539	CcSEcCtD
Imiquimod—Urticaria—Epirubicin—thyroid cancer	0.000383	0.000536	CcSEcCtD
Imiquimod—Pain—Doxorubicin—thyroid cancer	0.000381	0.000534	CcSEcCtD
Imiquimod—Abdominal pain—Epirubicin—thyroid cancer	0.000381	0.000534	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—thyroid cancer	0.000381	0.000534	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000368	0.00418	CbGpPWpGaD
Imiquimod—Feeling abnormal—Doxorubicin—thyroid cancer	0.000367	0.000515	CcSEcCtD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000366	0.00415	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000365	0.000511	CcSEcCtD
Imiquimod—Hypersensitivity—Epirubicin—thyroid cancer	0.000355	0.000497	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—thyroid cancer	0.000354	0.000496	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—thyroid cancer	0.000352	0.000494	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—thyroid cancer	0.000352	0.000494	CcSEcCtD
Imiquimod—Asthenia—Epirubicin—thyroid cancer	0.000346	0.000484	CcSEcCtD
Imiquimod—Pruritus—Epirubicin—thyroid cancer	0.000341	0.000478	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—KRAS—thyroid cancer	0.00034	0.00386	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PTEN—thyroid cancer	0.000335	0.00381	CbGpPWpGaD
Imiquimod—Diarrhoea—Epirubicin—thyroid cancer	0.00033	0.000462	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—thyroid cancer	0.000328	0.00046	CcSEcCtD
Imiquimod—Asthenia—Doxorubicin—thyroid cancer	0.00032	0.000448	CcSEcCtD
Imiquimod—Dizziness—Epirubicin—thyroid cancer	0.000319	0.000446	CcSEcCtD
Imiquimod—Pruritus—Doxorubicin—thyroid cancer	0.000315	0.000442	CcSEcCtD
Imiquimod—Vomiting—Epirubicin—thyroid cancer	0.000306	0.000429	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—thyroid cancer	0.000305	0.000427	CcSEcCtD
Imiquimod—Rash—Epirubicin—thyroid cancer	0.000304	0.000426	CcSEcCtD
Imiquimod—Dermatitis—Epirubicin—thyroid cancer	0.000304	0.000425	CcSEcCtD
Imiquimod—Headache—Epirubicin—thyroid cancer	0.000302	0.000423	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NRAS—thyroid cancer	0.000299	0.0034	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000298	0.00339	CbGpPWpGaD
Imiquimod—Dizziness—Doxorubicin—thyroid cancer	0.000295	0.000413	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000293	0.00333	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—HRAS—thyroid cancer	0.000289	0.00328	CbGpPWpGaD
Imiquimod—Nausea—Epirubicin—thyroid cancer	0.000286	0.000401	CcSEcCtD
Imiquimod—Vomiting—Doxorubicin—thyroid cancer	0.000283	0.000397	CcSEcCtD
Imiquimod—Rash—Doxorubicin—thyroid cancer	0.000281	0.000394	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—thyroid cancer	0.000281	0.000394	CcSEcCtD
Imiquimod—Headache—Doxorubicin—thyroid cancer	0.000279	0.000391	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000274	0.00311	CbGpPWpGaD
Imiquimod—Nausea—Doxorubicin—thyroid cancer	0.000265	0.000371	CcSEcCtD
Imiquimod—TLR8—Immune System—PTEN—thyroid cancer	0.000258	0.00292	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—KRAS—thyroid cancer	0.000257	0.00292	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—AKT1—thyroid cancer	0.000255	0.00289	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NRAS—thyroid cancer	0.00023	0.00261	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000228	0.00259	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HRAS—thyroid cancer	0.000219	0.00248	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000218	0.00248	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000205	0.00233	CbGpPWpGaD
Imiquimod—TLR8—Immune System—KRAS—thyroid cancer	0.000198	0.00225	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000196	0.00223	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTEN—thyroid cancer	0.000195	0.00222	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—thyroid cancer	0.000193	0.00219	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NRAS—thyroid cancer	0.000174	0.00198	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HRAS—thyroid cancer	0.000168	0.00191	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000167	0.00189	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000158	0.0018	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MINPP1—thyroid cancer	0.000151	0.00171	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KRAS—thyroid cancer	0.00015	0.0017	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—thyroid cancer	0.000148	0.00169	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NDUFA13—thyroid cancer	0.000128	0.00146	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HRAS—thyroid cancer	0.000127	0.00145	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CHST14—thyroid cancer	0.000121	0.00137	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000116	0.00132	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—thyroid cancer	0.000113	0.00128	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NDUFA13—thyroid cancer	9.9e-05	0.00112	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HPGD—thyroid cancer	9.72e-05	0.0011	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CHST14—thyroid cancer	9.31e-05	0.00106	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.88e-05	0.000895	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HPGD—thyroid cancer	7.5e-05	0.000852	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TPR—thyroid cancer	5.58e-05	0.000634	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	5.49e-05	0.000623	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.98e-05	0.000565	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TPR—thyroid cancer	4.31e-05	0.000489	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	4.24e-05	0.000481	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC5A5—thyroid cancer	4.18e-05	0.000474	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.92e-05	0.000445	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RXRA—thyroid cancer	3.51e-05	0.000399	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.42e-05	0.000388	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.23e-05	0.000366	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RXRA—thyroid cancer	2.71e-05	0.000308	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—thyroid cancer	2.22e-05	0.000252	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.74e-05	0.000198	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—thyroid cancer	1.71e-05	0.000194	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTEN—thyroid cancer	1.52e-05	0.000173	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.35e-05	0.000153	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTEN—thyroid cancer	1.17e-05	0.000133	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—thyroid cancer	8.77e-06	9.95e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—thyroid cancer	6.77e-06	7.68e-05	CbGpPWpGaD
